Total cohort (N = 79) | CAA (n = 50) | Non-CAA (n = 29) | P value | |
---|---|---|---|---|
Character | ||||
Age, median (range), year | 76(55–89) | 78(57–89) | 73(55–84) | 0.001 |
Female, No. (%) | 41(52) | 34 (68) | 7 (24) | < 0.001 |
Hypertension, No. (%) | 40(51) | 21 (42) | 19 (66) | 0.062 |
Diabetes, No. (%) | 7(9) | 2 (4) | 6 (21) | 0.025 |
Dementia, No. (%) | 17(22) | 15 (30) | 2 (7) | 0.022 |
Antithrombotic therapy, No. (%) | 30(38) | 16 (32) | 14 (48) | 0.229 |
Antiplatelets, No. (%) | 23(29) | 11(22) | 12(41) | 0.078 |
Anticoagulants, No. (%) | 11(14) | 5(10) | 6(21) | 0.162 |
Combination, No. (%) | 4(5) | 0 | 4(14) | 0.016 |
Postoperative rebleeding, No. (%) | 14(18) | 12(24) | 2(7) | 0.070 |
Hematoma vol. (before)*1, Mean (SD), mL | 82(33) | 82(33) | 83(33) | 0.866 |
Hematoma vol. (after)*2, Mean (SD), mL | 5.9(5.6) | 6.2(5.8) | 5.2(5.5) | 0.430 |